Pharmarise Holdings Corporation
Символ: 2796.T
JPX
659
JPYПазарна цена днес
24.6210
Съотношение P/E
-0.9450
Коефициент PEG
7.41B
MRK Cap
- 0.02%
Доходност на DIV
Pharmarise Holdings Corporation (2796-T) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 19706 | 4742 | 3991 | 4604 | ||||||||||||||||
balance-sheet.row.short-term-investments | -1926 | -1926 | -2079 | -2427 | ||||||||||||||||
balance-sheet.row.net-receivables | 7197 | 605 | 479 | 926 | ||||||||||||||||
balance-sheet.row.inventory | 11201 | 2290 | 2302 | 2587 | ||||||||||||||||
balance-sheet.row.other-current-assets | 1324 | 317 | 315 | 260 | ||||||||||||||||
balance-sheet.row.total-current-assets | 45540 | 11372 | 10878 | 10546 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 24233 | 6007 | 6355 | 6432 | ||||||||||||||||
balance-sheet.row.goodwill | 10471 | 2748 | 3220 | 4025 | ||||||||||||||||
balance-sheet.row.intangible-assets | 2096 | 501 | 408 | 438 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 12567 | 3249 | 3628 | 4463 | ||||||||||||||||
balance-sheet.row.long-term-investments | 10475 | 2008 | 2139 | 2488 | ||||||||||||||||
balance-sheet.row.tax-assets | -4368 | 778 | 741 | 786 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 7906 | 0 | 0 | 4 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 50813 | 12042 | 12863 | 14173 | ||||||||||||||||
balance-sheet.row.other-assets | 12 | 7 | 5 | 5 | ||||||||||||||||
balance-sheet.row.total-assets | 96365 | 23421 | 23746 | 24724 | ||||||||||||||||
balance-sheet.row.account-payables | 18505 | 4252 | 4109 | 4609 | ||||||||||||||||
balance-sheet.row.short-term-debt | 10986 | 3677 | 2490 | 2819 | ||||||||||||||||
balance-sheet.row.tax-payables | 1151 | 333 | 429 | 573 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 23993 | 5461 | 7422 | 7878 | ||||||||||||||||
Deferred Revenue Non Current | -42 | -42 | -31 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 42 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 4835 | 747 | 691 | 645 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 29391 | 6600 | 8571 | 9001 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 432 | 432 | 551 | 700 | ||||||||||||||||
balance-sheet.row.total-liab | 66052 | 16435 | 17048 | 18393 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 6518 | 1298 | 1274 | 1251 | ||||||||||||||||
balance-sheet.row.retained-earnings | 16234 | 4014 | 3811 | 3494 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 903 | 226 | 203 | 208 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 6281 | 1343 | 1319 | 1268 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 29936 | 6881 | 6607 | 6221 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 96362 | 23421 | 23746 | 24724 | ||||||||||||||||
balance-sheet.row.minority-interest | 374 | 105 | 91 | 110 | ||||||||||||||||
balance-sheet.row.total-equity | 30310 | 6986 | 6698 | 6331 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 96362 | - | - | - | ||||||||||||||||
Total Investments | 8549 | 82 | 60 | 61 | ||||||||||||||||
balance-sheet.row.total-debt | 34979 | 9138 | 9912 | 10697 | ||||||||||||||||
balance-sheet.row.net-debt | 15273 | 4396 | 5921 | 6093 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 302 | 1049 | 1322 | 1202 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 872 | 1224 | 1308 | 1344 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 513 | -1465 | -139 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 482 | -1319 | 365 | ||||||||||||||||
cash-flows.row.inventory | 0 | 68 | 286 | 56 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 13 | -500 | -582 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -50 | 68 | 22 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -302 | -266 | -452 | -462 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1744 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -542 | -466 | -552 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -180 | 2 | -116 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -2 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 383 | 12 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 19 | -209 | -418 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -703 | -292 | -1076 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | -2419 | -2636 | -2857 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 1737 | 2199 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -2 | -36 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | -131 | -131 | -129 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 1478 | -2 | 95 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -1072 | -1034 | -728 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -2 | 0 | -1 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 502 | 743 | -613 | 140 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 14542 | 4734 | 3991 | 4604 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 14040 | 3991 | 4604 | 4464 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 1744 | 2520 | 713 | 1945 | ||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -542 | -466 | -552 | ||||||||||||||||
cash-flows.row.free-cash-flow | 1744 | 1978 | 247 | 1393 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 53974 | 52030 | 51608 | 52324 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 45538 | 43896 | 43491 | 44256 | ||||||||||||||||
income-statement-row.row.gross-profit | 8436 | 8134 | 8117 | 8068 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 22 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | -22 | 32 | -7 | 21 | ||||||||||||||||
income-statement-row.row.operating-expenses | 7031 | 6695 | 6596 | 6821 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 52569 | 50591 | 50087 | 51077 | ||||||||||||||||
income-statement-row.row.interest-income | 28 | 1 | 1 | 1 | ||||||||||||||||
income-statement-row.row.interest-expense | 57 | 55 | 65 | 75 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -315 | -390 | -200 | -45 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | -22 | 32 | -7 | 21 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -315 | -390 | -200 | -45 | ||||||||||||||||
income-statement-row.row.interest-expense | 57 | 55 | 65 | 75 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 916 | 1224 | 1308 | 1344 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 1719 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | 1404 | 1438 | 1520 | 1246 | ||||||||||||||||
income-statement-row.row.income-before-tax | 1088 | 1049 | 1322 | 1202 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 772 | 702 | 863 | 782 | ||||||||||||||||
income-statement-row.row.net-income | 301 | 333 | 447 | 426 |
Често задавани въпроси
Какво е Pharmarise Holdings Corporation (2796.T) общи активи?
Pharmarise Holdings Corporation (2796.T) общите активи са 23421000000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 27203000000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 152.963.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 152.963.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.006.
Какъв е общият приход на предприятието?
Общият приход е 0.026.
Каква е Pharmarise Holdings Corporation (2796.T) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 333000000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 9138000000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 6695000000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 5164000000.000.